Founded: 2024
Founders: Linden Schrecker, Cristian Holtze (BASF), Mimi Hill and Klaus Hellgardt
CEO: Linden Schrecker
Born out of a collaborative research effort between 51³Ô¹ÏÍø and BASF, SOLVE Chemistry was created to tackle a persistent industrial bottleneck: once a promising molecule has been discovered, scaling its production into a robust, economical, and sustainable manufacturing process remains slow, costly, and uncertain. The spin-out combines proprietary high-throughput experimentation with machine learning to generate the reaction data needed to identify better process conditions quicker, helping chemical manufacturers reduce waste, lower energy use, and move from laboratory success to industrial reality with greater confidence and speed.
SOLVE Chemistry sits at the intersection of two major shifts: the digitisation of chemistry and the growing need for more sustainable, rapid production across pharmaceuticals, agrochemicals, and specialty chemicals at commercial scale. This positioning has helped the company move quickly from spin-out to commercial scale-up, expanding from 51³Ô¹ÏÍø’s White City ecosystem into larger facilities at Scale Space while working with industrial partners on real manufacturing challenges.
SOLVE Chemistry first completed a £780k pre-seed round in April 2024, followed by a £4 million seed round in January 2026, led by XTX Ventures and joined by SuperSeed, Creator Fund, Endgame Capital, Inovia Capital, Redbus Ventures, and industry expert angels. It is also part of a UK consortium awarded £7mn by Innovate UK and the Department of Health and Social Care to accelerate low-carbon medicines manufacturing and IConIC, an £18mn UK prosperity partnership focused on continuous chemical processing technologies.
Media:
/news/articles/2025/imperial-and-solve-chemistry-bring-chemical-reaction-data-to-machine-learning/